// App-Quantinova.ai

5121 : Immunomodulating cytokine profiling of docetaxel-treated human prostate cancer specimens

Researchers

Presenter

  • Debapriya G. Mehrotra

Principal Investigators

  • Nilesh Brijwani

  • Biplab Tewary

  • Vasathkumar Sekar

  • Abhishek Krishnan

  • Dency D. Pinto

  • Muthusamy Oliyarasi

  • Biswanath Majumder

  • Saravanan Thiyagarajan

  • Padhma Radhakrishnan

  • Pradip K. Majumder

Medical Centers

  • Mitra Biotech Pvt Ltd., Bangalore, India

  • Mitra Biotech, Boston, MA.

Locations

  • United States

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

  • Prostate cancer

  • Solid malignancies

Biomarkers

  • Peripheral blood mononuclear cell

  • Cluster of Differentiation 4

  • Cluster of differentiation 45

  • Cluster of differentiation 69

  • Programmed cell death protein 1

  • Programmed death-ligand 1

  • Cluster of differentiation 8A

Drug/Treatment

  • Docetaxel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved